Explore
Validate
LearnMA1-26379
antibody from Invitrogen Antibodies
Targeting: RET
CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-26379 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Anti-RET Monoclonal Antibody (RET01)
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- MA1-26415 detects Caspase 3 from human samples. MA1-26415 has been successfully used in immunoprecipitation, immunohistochemistry, and Western blot procedures. Positive control of tonsil suggested. The MA1-26415 immunogen is recombinant, full length human protein.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- RET01
- Vial size
- 500 µL
- Concentration
- Lot Dependent
- Storage
- 4° C, do not freeze
Submitted references New insights into c-Ret signalling pathway in the enteric nervous system and its relationship with ALS.
Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.
Luesma MJ, Cantarero I, Álvarez-Dotu JM, Santander S, Junquera C
BioMed research international 2014;2014:328348
BioMed research international 2014;2014:328348
Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.
Styring E, Seinen J, Dominguez-Valentin M, Domanski HA, Jönsson M, von Steyern FV, Hoekstra HJ, Suurmeijer AJ, Nilbert M
British journal of cancer 2014 Jul 15;111(2):407-12
British journal of cancer 2014 Jul 15;111(2):407-12
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Bentzien F, Zuzow M, Heald N, Gibson A, Shi Y, Goon L, Yu P, Engst S, Zhang W, Huang D, Zhao L, Vysotskaia V, Chu F, Bautista R, Cancilla B, Lamb P, Joly AH, Yakes FM
Thyroid : official journal of the American Thyroid Association 2013 Dec;23(12):1569-77
Thyroid : official journal of the American Thyroid Association 2013 Dec;23(12):1569-77
Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.
Powers JF, Brachold JM, Tischler AS
Endocrine pathology 2003 Winter;14(4):351-61
Endocrine pathology 2003 Winter;14(4):351-61
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of RET in formalin-fixed, paraffin-embedded human small intestine tissue using a RET monoclonal antibody (Product # MA1-26379).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of RET using a RET monoclonal antibody (Product # MA1-26379).
